rdf:type |
|
lifeskim:mentions |
umls-concept:C0014994,
umls-concept:C0086418,
umls-concept:C0439799,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C1314792,
umls-concept:C1413135,
umls-concept:C1552599,
umls-concept:C1631597,
umls-concept:C1704787,
umls-concept:C1709059,
umls-concept:C1880177,
umls-concept:C1939700
|
pubmed:issue |
4-5
|
pubmed:dateCreated |
2010-11-10
|
pubmed:abstractText |
The plateau phase of the ventricular action potential is the result of balanced Ca(2+) influx and K(+) efflux. The action potential is terminated by repolarizing K(+) currents. Under ?-adrenergic stimulation, both the Ca(2+)-influx and the delayed rectifier K(+) currents I(K) are stimulated to adjust the cardiac action potential duration to the enhanced heart rate and to ascertain adequate increase in net Ca(2+) influx. Intracellularly, a Calsequestrin2 (CASQ2)-ryanodine receptor complex serves as the most effective Ca(2+) reservoir/release system to aid the control of intracellular Ca(2+) levels. Currently, it is unclear if disease-associated CASQ2 gene variants alter intracellular free Ca(2+) concentrations and if cardiac ion channels are affected by it.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1421-9778
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-12
|
pubmed:meshHeading |
pubmed-meshheading:21063088-Action Potentials,
pubmed-meshheading:21063088-Amino Acid Substitution,
pubmed-meshheading:21063088-Animals,
pubmed-meshheading:21063088-Calcium,
pubmed-meshheading:21063088-Calsequestrin,
pubmed-meshheading:21063088-Ether-A-Go-Go Potassium Channels,
pubmed-meshheading:21063088-Humans,
pubmed-meshheading:21063088-Molecular Dynamics Simulation,
pubmed-meshheading:21063088-Mutation,
pubmed-meshheading:21063088-Oocytes,
pubmed-meshheading:21063088-Potassium,
pubmed-meshheading:21063088-Protein Structure, Tertiary,
pubmed-meshheading:21063088-Ryanodine Receptor Calcium Release Channel,
pubmed-meshheading:21063088-Tachycardia, Ventricular,
pubmed-meshheading:21063088-Xenopus
|
pubmed:year |
2010
|
pubmed:articleTitle |
Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT).
|
pubmed:affiliation |
Department of Biochemistry I, Ruhr-University Bochum, Bochum, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|